Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Emery

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Project Phidisa: development of clinical research capacity within the South African National Defence ForceNtsiki Motumi, Sean Emery, H Clifford Lane
Current Opinion in HIV and AIDS|October 28, 2010
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010James D Neaton, Jacqueline Neuhaus, Sean Emery
Drugs|June 4, 2010
Role of interleukin-2 in patients with HIV infectionSarah L Pett, Anthony D Kelleher, Sean Emery
The Medical Journal of Australia|November 23, 2006
Antivirals in the management of an influenza pandemicMary Ellen Harrod, Sean Emery, Dominic E Dwyer
The Journal of Infectious Diseases|February 15, 2001
ReplySean Emery, H. Clifford Lane, James D. Neaton
The Journal of Infectious Diseases|April 19, 2008
Disease progression and fatal outcomes in HIV-infected patients during interruption of antiretroviral treatmentDavid A Cooper, Sean Emery, Damien V Cordery
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trialsDianne Carey, Janaki Amin, Mark Boyd, et al.
AIDS Research and Human Retroviruses|April 21, 2006
Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individualsAlan Winston, Janaki Amin, Gill Hales, et al.
Diabetes Care|December 29, 2006
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemiaKatherine Samaras, Handan Wand, Matthew Law, et al.
Current HIV Research|July 16, 2009
Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolismKatherine Samaras, Handan Wand, Matthew Law, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Current Opinion in HIV and AIDS|April 18, 2009
Project Phidisa: development of clinical research capacity within the South African National Defence ForceNtsiki Motumi, Sean Emery, H Clifford Lane
Current Opinion in HIV and AIDS|October 28, 2010
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010James D Neaton, Jacqueline Neuhaus, Sean Emery
Drugs|June 4, 2010
Role of interleukin-2 in patients with HIV infectionSarah L Pett, Anthony D Kelleher, Sean Emery
The Medical Journal of Australia|November 23, 2006
Antivirals in the management of an influenza pandemicMary Ellen Harrod, Sean Emery, Dominic E Dwyer
The Journal of Infectious Diseases|February 15, 2001
ReplySean Emery, H. Clifford Lane, James D. Neaton
The Journal of Infectious Diseases|April 19, 2008
Disease progression and fatal outcomes in HIV-infected patients during interruption of antiretroviral treatmentDavid A Cooper, Sean Emery, Damien V Cordery
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trialsDianne Carey, Janaki Amin, Mark Boyd, et al.
AIDS Research and Human Retroviruses|April 21, 2006
Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individualsAlan Winston, Janaki Amin, Gill Hales, et al.
Diabetes Care|December 29, 2006
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemiaKatherine Samaras, Handan Wand, Matthew Law, et al.
Current HIV Research|July 16, 2009
Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolismKatherine Samaras, Handan Wand, Matthew Law, et al.
Pageof 14